Skip to main content

Hopfner Robert Lorne

In the past year, 1 open-market purchase filing worth $17.4K and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$17.4K
1 filing
Sold
–
0 filings
Net
+$17.4K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Hopfner Robert Lorne as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

EVMN Evommune, Inc.

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 22, 2025 (view filing)Dec 193 daysHopfner Robert LorneDirector, 10% OwnerPPurchase+1.00K$17.35+$17.4K+33.0%4.03K after

INZY Inozyme Pharma, Inc.

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 3, 2023 (view filing)Aug 12 daysHopfner Robert LorneDirectorPPurchase+833.3K$4.80+$4.00M+112.9%1.57M after2 lots
May 15, 2023 (view filing)May 11-124 daysHopfner Robert LorneDirectorPPurchase+447.9K$6.36+$2.85M+13.9%3.66M after2 lots
Mar 30, 2023 (view filing)Mar 291 dayHopfner Robert LorneDirectorPPurchase+344.6K$4.54+$1.56M+12.0%3.21M after
Mar 29, 2023 (view filing)Mar 27-282 daysHopfner Robert LorneDirectorPPurchase+207.8K$4.05+$841.1K+7.8%2.87M after2 lots
Apr 20, 2022 (view filing)Apr 191 dayHopfner Robert LorneDirectorPPurchase+1.07M$3.69+$3.95M+67.2%2.66M after

RLYB Rallybio Corp

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 4, 2021 (view filing)Aug 22 daysHopfner Robert LorneDirectorPPurchase+576.9K$13.00+$7.50M+34.1%2.27M after